Marmura Michael J, Goldberg Stephanie Wrobel
Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, 900 Walnut St. Suite 200, Philadelphia, PA, 19107, USA,
Curr Neurol Neurosci Rep. 2015 Apr;15(4):13. doi: 10.1007/s11910-015-0539-z.
Migraine is a frequently disabling disorder which may require inpatient treatment. Admission criteria for migraine include intractable migraine, nausea and/or vomiting, severe disability, and dependence on opioids or barbiturates. The inpatient treatment of migraine is based on observational studies and expert opinion rather than placebo-controlled trials. Well-established inpatient treatments for migraine include dihydroergotamine, neuroleptics/antiemetics, lidocaine, intravenous aspirin, and non-pharmacologic treatment such as cognitive-behavioral therapy. Short-acting treatments possibly associated with medication overuse, such as triptans, opioids, or barbiturate-containing compounds, are generally avoided. While the majority of persons with migraine are admitted on an emergency basis for only a few days, outcome studies and infusion protocols during elective admissions at tertiary headache centers suggest a longer length of stay may be needed for persons with intractable migraine.
偏头痛是一种常导致功能障碍的疾病,可能需要住院治疗。偏头痛的住院标准包括顽固性偏头痛、恶心和/或呕吐、严重功能障碍以及对阿片类药物或巴比妥类药物的依赖。偏头痛的住院治疗基于观察性研究和专家意见,而非安慰剂对照试验。公认的偏头痛住院治疗方法包括双氢麦角胺、抗精神病药/止吐药、利多卡因、静脉注射阿司匹林以及认知行为疗法等非药物治疗。通常避免使用可能与药物过度使用相关的短效治疗方法,如曲坦类药物、阿片类药物或含巴比妥类化合物。虽然大多数偏头痛患者仅在紧急情况下住院几天,但三级头痛中心择期入院期间的疗效研究和输液方案表明,顽固性偏头痛患者可能需要更长的住院时间。